Renaissance Technologies’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
11,629,896
+10,412,028
+855% +$2.91M ﹤0.01% 1973
2026
Q1
$400K Buy
1,217,868
+558,980
+85% +$879K ﹤0.01% 2692
2025
Q4
$2.04M Sell
658,888
-2,321,300
-78% -$6.62M ﹤0.01% 1848
2025
Q3
$7.84M Buy
2,980,188
+247,894
+9% +$546K 0.01% 1210
2025
Q2
$3.36M Buy
2,732,294
+1,163,139
+74% +$1.27M ﹤0.01% 1774
2025
Q1
$1.73M Sell
1,569,155
-143,348
-8% -$166K ﹤0.01% 2101
2024
Q4
$1.55M Sell
1,712,503
-32,302
-2% -$27.7K ﹤0.01% 2215
2024
Q3
$1.72M Sell
1,744,805
-301,795
-15% -$290K ﹤0.01% 2122
2024
Q2
$1.84M Buy
2,046,600
+1,375,000
+205% +$1.03M ﹤0.01% 1926
2024
Q1
$792K Sell
671,600
-325,401
-33% -$358K ﹤0.01% 2633
2023
Q4
$910K Buy
+997,001
New +$736K ﹤0.01% 2469
2022
Q4
Sell
-35,800
Closed -$429K 4219
2022
Q3
$429K Sell
35,800
-33,100
-48% -$411K ﹤0.01% 3017
2022
Q2
$577K Sell
68,900
-63,200
-48% -$490K ﹤0.01% 3074
2022
Q1
$1.15M Buy
132,100
+88,400
+202% +$853K ﹤0.01% 2647
2021
Q4
$494K Buy
+43,700
New +$519K ﹤0.01% 3080
2021
Q2
Sell
-150,000
Closed -$1.39M 3577
2021
Q1
$1.39M Sell
150,000
-32,800
-18% -$331K ﹤0.01% 2442
2020
Q4
$1.77M Sell
182,800
-152,800
-46% -$1.51M ﹤0.01% 2196
2020
Q3
$4.17M Sell
335,600
-28,000
-8% -$371K ﹤0.01% 1674
2020
Q2
$4.73M Buy
363,600
+266,138
+273% +$3.35M ﹤0.01% 1676
2020
Q1
$989K Buy
+97,462
New +$1.27M ﹤0.01% 2431

Other funds holding GOSS

Renaissance Technologies's GOSS Position: Q2 2026 in Review

Renaissance Technologies increased its Gossamer Bio (GOSS) stake by 855% in Q2 2026, buying an estimated $2.91M and bringing the position to 11,629,896 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Renaissance Technologies first reported a position in GOSS in Q1 2020 and has held it in 20 quarters since. The position peaked at $7.84M in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Renaissance Technologies held 11,629,896 shares of Gossamer Bio worth $1.91M as of Q2 2026.
  • Renaissance Technologies bought 10,412,028 Gossamer Bio shares in Q2 2026, an estimated $2.91M.
  • Gossamer Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1973 holding.
  • Renaissance Technologies first reported a position in Gossamer Bio in Q1 2020 and has held it in 20 quarters since.
  • Renaissance Technologies's Gossamer Bio position peaked at $7.84M in Q3 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.